98 related articles for article (PubMed ID: 6533910)
1. Mechanisms of neutropenia in hemodialysis (HD).
Camussi G; Pacitti A; Tetta C; Bellone G; Mangiarotti G; Canavese C; Segoloni G; Vercellone A
Trans Am Soc Artif Intern Organs; 1984; 30():364-9. PubMed ID: 6533910
[No Abstract] [Full Text] [Related]
2. Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis.
Stroncek DF; Keshaviah P; Craddock PR; Hammerschmidt DE
J Lab Clin Med; 1984 Sep; 104(3):304-11. PubMed ID: 6470561
[TBL] [Abstract][Full Text] [Related]
3. Complement activation and serum beta-glucuronidase level during hemodialysis.
Kural N; Saatçi U; Bakkaloglu A
Child Nephrol Urol; 1988-1989; 9(1-2):69-71. PubMed ID: 3251624
[TBL] [Abstract][Full Text] [Related]
4. Modified neutropenic response to re-used dialyzers in patients with chronic renal failure.
Savdie E; Bruce L; Vincent PC
Clin Nephrol; 1977 Oct; 8(4):422-8. PubMed ID: 923160
[No Abstract] [Full Text] [Related]
5. [Activation of the complement system during chronic hemodialysis].
Rus HG; Cristea A; Gherman M; Manasia M
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(3):275-81. PubMed ID: 6138841
[No Abstract] [Full Text] [Related]
6. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
Schindler R; Marra MN; McKelligon BM; Lonnemann G; Schulzeck P; Schulze M; Oppermann M; Shaldon S
Clin Nephrol; 1993 Dec; 40(6):346-51. PubMed ID: 7507806
[TBL] [Abstract][Full Text] [Related]
8. [Activation of the complement system in the course of chronic hemodialysis].
Rus HG; Cristea A; Gherman M; Manasia M
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(3):275-81. PubMed ID: 6132439
[No Abstract] [Full Text] [Related]
9. Platelet aggregation before and after hemodialysis in chronic renal insufficiency.
Kageyama T; Oyabu H; Tsumoto S; Kimoto S; Toda H
Bull Osaka Med Sch; 1983 Oct; 29(2):62-8. PubMed ID: 6680327
[No Abstract] [Full Text] [Related]
10. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis.
Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M
Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
13. Nutrition and hydration status improve with exercise training using stationary cycling during hemodialysis (HD) in patients with end-stage renal disease (ESRD).
Załuska A; Załuska WT; Bednarek-Skublewska A; Ksiazek A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):342-6. PubMed ID: 12898860
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
[TBL] [Abstract][Full Text] [Related]
15. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment.
Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D
Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465
[TBL] [Abstract][Full Text] [Related]
16. [Modifications of hemorheologic parameters in the course of hemodialysis in chronic renal insufficiency].
Houbouyan L; Stoltz JF; Beauchet A; Consoli N; Prinseau J; Baglin A; Goguel A
J Mal Vasc; 1994; 19(2):132-6. PubMed ID: 8077862
[TBL] [Abstract][Full Text] [Related]
17. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
18. Chronic idiopathic neutropenia.
Joyce RA
N Engl J Med; 1980 Aug; 303(9):524-5. PubMed ID: 7393302
[No Abstract] [Full Text] [Related]
19. The effect of r-hirudin vs. heparin on blood-membrane interactions during hemodialysis.
van Wyk V; Badenhorst PN; Kotzé HF
Clin Nephrol; 1997 Dec; 48(6):381-7. PubMed ID: 9438098
[TBL] [Abstract][Full Text] [Related]
20. Trace element status of chronic renal patients undergoing hemodialysis.
Kiziltas H; Ekin S; Erkoc R
Biol Trace Elem Res; 2008 Aug; 124(2):103-9. PubMed ID: 18414814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
